What is Enflurane used for?
Enflurane, a volatile liquid anesthetic agent, has carved a notable position in the realm of anesthesia since its introduction in the 1960s. Known by its trade name, Ethrane, this halogenated ether has been widely used in surgical settings to induce and maintain general anesthesia. Developed by Ross Terrell and introduced by Abbott Laboratories, Enflurane quickly gained prominence due to its favorable pharmacokinetic properties and manageable side effect profile. The drug primarily targets the central nervous system to induce a reversible loss of consciousness and sensation, making it a valuable tool in various surgical procedures.
Classified under the category of inhalational anesthetics, Enflurane's primary indication is for the induction and maintenance of general anesthesia. Its use spans across both minor and major surgical procedures. Since its introduction, extensive research has been conducted to understand its pharmacodynamics, pharmacokinetics, and safety profile. While newer agents like sevoflurane and desflurane have become more popular in recent years, Enflurane remains a relevant topic of study, particularly in understanding the history and evolution of anesthetic agents.
Researching Enflurane beyond the basics?
Synapse Hiro LS Researcher, the Synapse AI Insight Engine, is built to accelerate biopharma decisions. Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence. Explore Enflurane with Hiro LS Researcher →
Enflurane exerts its anesthetic effects primarily through its action on the central nervous system. Although the exact mechanism of action is not completely understood, it is believed to involve modulation of the activity of various ion channels in the brain and spinal cord. Enflurane enhances the inhibitory effects of gamma-aminobutyric acid (GABA) at the GABA_A receptor, leading to increased chloride ion influx and hyperpolarization of neurons. This action results in the dampening of neuronal excitability and the induction of anesthesia.
Additionally, Enflurane has been shown to inhibit excitatory neurotransmitter release by affecting ion channels such as NMDA (N-methyl-D-aspartate) receptors. This dual action on inhibitory and excitatory pathways contributes to its overall anesthetic effect. Enflurane also reduces the metabolic rate of the brain, leading to decreased cerebral oxygen consumption, which can be particularly beneficial during neurosurgical procedures.
Enflurane is administered through inhalation, using a vaporizer specifically calibrated for this agent. The administration of Enflurane involves a stepwise approach, starting with induction and followed by maintenance of anesthesia. During the induction phase, the anesthetist typically administers a mix of Enflurane and oxygen, gradually increasing the concentration until the patient loses consciousness. The onset time for Enflurane's anesthetic effects is relatively rapid, usually within a few minutes, making it suitable for both scheduled and emergency surgeries.
Once the desired level of anesthesia is achieved, the maintenance phase involves adjusting the concentration of Enflurane to sustain the anesthetic state throughout the surgical procedure. The precise concentration required can vary depending on factors such as the patient's age, weight, and overall health. Monitoring of vital signs, including heart rate, blood pressure, and oxygen saturation, is critical during this phase to ensure patient safety.
Following the completion of surgery, the administration of Enflurane is gradually tapered off, allowing the patient to regain consciousness. The recovery time can vary, but patients typically begin to awaken within a few minutes after the discontinuation of the anesthetic agent. Post-operative monitoring is essential to ensure a smooth recovery and to address any potential complications.
Like all anesthetic agents, Enflurane is associated with a range of side effects and contraindications. Common side effects include nausea, vomiting, dizziness, and shivering. These effects are generally transient and resolve as the anesthetic wears off. However, more serious side effects can occur, particularly with prolonged use or in patients with pre-existing health conditions. These may include hypotension (low blood pressure), respiratory depression, and arrhythmias (irregular heartbeats).
Enflurane is contraindicated in patients with a history of malignant hyperthermia, a rare but life-threatening reaction to certain anesthetic agents. It is also contraindicated in individuals with known hypersensitivity to halogenated anesthetics. Patients with severe liver or kidney disease should be administered Enflurane with caution, as it can exacerbate these conditions. Additionally, Enflurane can increase intracranial pressure, making it unsuitable for patients with head injuries or conditions that predispose them to elevated intracranial pressure.
The use of Enflurane can be influenced by the administration of other medications. Drugs that induce liver enzymes, such as barbiturates and phenytoin, can increase the metabolism of Enflurane, potentially reducing its efficacy. Conversely, drugs that inhibit liver enzymes, such as certain antibiotics and antifungals, can prolong the effects of Enflurane by slowing its metabolism.
Other anesthetic agents, both inhalational and intravenous, can interact with Enflurane, either enhancing or diminishing its effects. For instance, the concurrent use of other volatile anesthetics like halothane or isoflurane can potentiate the anesthetic effects, requiring careful dose adjustments. Additionally, opioid analgesics, muscle relaxants, and sedative-hypnotics can interact with Enflurane, necessitating careful monitoring and dose titration to avoid excessive sedation or respiratory depression.
In summary, Enflurane remains a significant anesthetic agent with a well-documented history of use in surgical settings. Its mechanism of action involves modulation of neuronal activity through ion channels, leading to effective induction and maintenance of anesthesia. While generally well-tolerated, Enflurane is associated with a range of side effects and contraindications that must be carefully considered in clinical practice. The interactions of Enflurane with other drugs necessitate vigilant monitoring and dose adjustments to ensure patient safety and optimal anesthetic outcomes.
Continue your Enflurane research with Synapse Hiro LS Researcher
This article provides an overview. For a broader research view, use Synapse Hiro LS Researcher—the Synapse AI Insight Engine—to search across drugs, targets, indications, clinical trials, literature, organizations, news, deals, and competitor signals. Ask any biopharma research question in natural language.
Questions to explore:
- What approved and investigational uses have been reported for Enflurane?
- What is the mechanism of action of Enflurane, and which targets or pathways are involved?
- Which clinical trials are evaluating Enflurane, and what outcomes have been reported?
- What patents, publications, and regulatory sources provide the latest evidence on Enflurane?
Ask Synapse Hiro LS Researcher →
AI may make mistakes. Check important info.